Enterprise Value
16.69M
Cash
17.26M
Avg Qtr Burn
-18.43M
Short % of Float
1.18%
Insider Ownership
0.14%
Institutional Own.
12.86%
Qtr Updated
09/30/23
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EDP1815 Details Atopic dermatitis | Failed Discontinued | |
EDP1815 Details COVID-19 | Failed Discontinued | |
EDP1815 Details Psoriasis | Failed Discontinued | |
EDP1867 Details Atopic dermatitis | Failed Discontinued | |
EDP2939 Details Psoriasis | Failed Discontinued |